UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $17.32, for a total transaction of $779,400.00. Following the completion of the transaction, the chief executive officer directly owned 28,298,585 shares of the company’s stock, valued at approximately $490,131,492.20. This represents a 0.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Monday, January 5th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $15.73, for a total transaction of $707,850.00.
- On Friday, January 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.38, for a total value of $737,100.00.
- On Wednesday, December 31st, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.55, for a total value of $744,750.00.
- On Monday, December 29th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.44, for a total value of $739,800.00.
- On Friday, December 26th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.90, for a total transaction of $760,500.00.
- On Wednesday, December 24th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.91, for a total transaction of $760,950.00.
- On Monday, December 22nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.49, for a total value of $742,050.00.
- On Friday, December 19th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.07, for a total transaction of $723,150.00.
- On Wednesday, December 17th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.11, for a total value of $724,950.00.
- On Monday, December 15th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $17.30, for a total transaction of $778,500.00.
UiPath Trading Up 2.7%
Shares of NYSE PATH opened at $17.81 on Thursday. The business has a 50-day moving average price of $15.61 and a two-hundred day moving average price of $13.75. The firm has a market capitalization of $9.52 billion, a PE ratio of 42.39, a PEG ratio of 5.08 and a beta of 1.08. UiPath, Inc. has a one year low of $9.38 and a one year high of $19.84.
Analyst Ratings Changes
PATH has been the topic of a number of research analyst reports. Morgan Stanley raised their target price on UiPath from $15.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, December 9th. Wall Street Zen lowered shares of UiPath from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 6th. UBS Group reissued a “neutral” rating on shares of UiPath in a research note on Thursday, December 4th. Canaccord Genuity Group raised their price target on shares of UiPath from $15.00 to $19.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $15.85.
Hedge Funds Weigh In On UiPath
Several institutional investors have recently bought and sold shares of the business. D.A. Davidson & CO. increased its stake in shares of UiPath by 23.8% in the 3rd quarter. D.A. Davidson & CO. now owns 752,448 shares of the company’s stock valued at $10,068,000 after acquiring an additional 144,832 shares during the last quarter. Inspire Investing LLC acquired a new position in UiPath during the second quarter valued at approximately $891,000. AlphaQuest LLC grew its holdings in shares of UiPath by 863.9% in the 2nd quarter. AlphaQuest LLC now owns 42,847 shares of the company’s stock valued at $548,000 after buying an additional 38,402 shares during the period. Russell Investments Group Ltd. increased its position in shares of UiPath by 7.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 1,445,644 shares of the company’s stock valued at $18,448,000 after buying an additional 98,058 shares in the last quarter. Finally, Pallas Capital Advisors LLC increased its position in shares of UiPath by 24.8% in the 2nd quarter. Pallas Capital Advisors LLC now owns 105,834 shares of the company’s stock valued at $1,355,000 after buying an additional 21,058 shares in the last quarter. Institutional investors own 62.50% of the company’s stock.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Further Reading
- Five stocks we like better than UiPath
- You Still Think Silver’s a Joke? Watch What Happens Next.
- This week’s 20x (missed it?)
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
